{"comparisonGroups":["Control_Liver","Treatment_Liver"],"dateCreated":"2025-09-26 00:00:00","display_title":"Liver: DT-109 compound treatment vs H2O control","group_a_title":"Control group for liver samples treated with H20 (vehicle).. Provides baseline data for liver tissue to compare against treatment effects.","group_b_title":"Treatment group for liver samples treated with DT-109 (compound).. Evaluates the effect of DT-109 on liver tissue, providing insights into its therapeutic potential.","id":"MTBLS5005_0002_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":16,"studyId":"MTBLS5005","studyUrl":"http://integmet.org/study/MTBLS5005","title":"Control_Liver_vs_Treatment_Liver","topHits":[{"chebi_id":"184896","direction":"down","inn_name":"","iupac_name":"[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (Z)-docos-13-enoate","metabolite_id":"ALWGEKGYDBQVFJ-DYFSFZQGSA-N","pvalue":0.0257949534764403,"ratio":0.0642781046264666,"synonym_name":""},{"chebi_id":"74535","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>,3<i>R</i>,4<i>E</i>)-3-hydroxy-2-[(15<i>Z</i>)-tetracos-15-enoylamino]octadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"WKZHECFHXLTOLJ-QYKFWSDSSA-N","pvalue":0.0063100883190183,"ratio":5.4623272016862225,"synonym_name":"C24:1 Sphingomyelin"},{"chebi_id":"86102","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"SRQSAJRUMDQMMS-NLDJLLEISA-N","pvalue":0.0140818469822176,"ratio":0.1567928147999389,"synonym_name":"PC(14:0/20:4)"},{"chebi_id":"189014","direction":"up","inn_name":"","iupac_name":"3,4,5-trihydroxy-6-[1-(4-methoxyphenyl)-3-oxopentoxy]oxane-2-carboxylic acid","metabolite_id":"TWSHGCHPGCBTFY-UHFFFAOYSA-N","pvalue":0.0230166199333467,"ratio":5.948552315955247,"synonym_name":""},{"chebi_id":"175838","direction":"up","inn_name":"","iupac_name":"8-[6-hydroxy-5-(3-methylbut-2-enyl)-1-benzouran-2-yl]-2,2-dimethylchromen-5-ol","metabolite_id":"AKOSXIFOBUWPLU-UHFFFAOYSA-N","pvalue":0.0152173221469818,"ratio":4.010811007967077,"synonym_name":""},{"chebi_id":"63791","direction":"down","inn_name":"lenalidomide","iupac_name":"3-(4-amino-1-oxo-1,3-dihydro-2<em>H</em>-isoindol-2-yl)piperidine-2,6-dione","metabolite_id":"GOTYRUGSSMKFNF-UHFFFAOYSA-N","pvalue":0.0073110662962678,"ratio":0.3175633550067193,"synonym_name":"1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline"},{"chebi_id":"88773","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"OKNSFVSKHQJVRN-XAYCFROHSA-N","pvalue":0.0194844821222233,"ratio":3.738905427769356,"synonym_name":"20beta-Cortolone-3-glucuronide"},{"chebi_id":"78745","direction":"up","inn_name":"","iupac_name":"(11<i>R</i>)-11-[3,6-dideoxy-4-<em>O</em>-(1<em>H</em>-indol-3-ylcarbonyl)-\u03b1-<small>L</small>-<i>arabino</i>-hexopyranosyloxy]dodecanoic acid","metabolite_id":"AFPJDDPSVYDRDB-DRONAGRDSA-N","pvalue":0.0479737742011962,"ratio":4.842515988967167,"synonym_name":"(11<i>R</i>)-11-[3,6-dideoxy-4-<em>O</em>-(1<em>H</em>-indol-3-ylcarbonyl)-\u03b1-<small>L</small>-<i>arabino</i>-hexopyranosyloxy]lauric acid"},{"chebi_id":"179993","direction":"down","inn_name":"","iupac_name":"4-methyl-2-propan-2-yl-1,3-dioxolane","metabolite_id":"NWXXKKDLGZLEGH-UHFFFAOYSA-N","pvalue":0.0017381841862606,"ratio":0.484822861442773,"synonym_name":""},{"chebi_id":"5556","direction":"down","inn_name":"","iupac_name":"1-(1,4-dioxaspiro[4.5]dec-2-ylmethyl)guanidine sulfate","metabolite_id":"RTEVGQJRTFFMLL-UHFFFAOYSA-N","pvalue":0.0286938157329504,"ratio":0.2838649126147201,"synonym_name":"U 28288D"}],"totalFeatures":16}